Sinead Knight
Sygnature Discovery
Sinead Knight is listed at Sygnature Discovery. Sinead is scheduled to speak at SLAS 2027 International Conference & Exhibition on 30 January 2027.
Compiled from published conference agendas; not yet confirmed by Sinead. Is this you? Claim this profile.
About
Sinéad received her PhD in Genetics from Trinity college Dublin, Ireland before moving quickly to the biotech industry. With almost twenty years of industrial experience in biotech and biopharmaceuticals, Sinéad is an expert in the field of drug discovery, small molecule screening, target identification and target validation. Sinéad is currently Senior Principal Scientist and Section Head at Sygnature Discovery working closely with SMEs and biotech companies to develop and progress drug discovery projects from early hit identification in high-throughput screening through to lead optimisation and candidate selection. Sinéad’s previous roles include Associate Principal Scientist within the Functional Genomics and High Content Biology groups in AstraZeneca. Sinéad is currently an Associate Editor for SLAS Discovery and an SLAS Fellow
Upcoming
SLAS 2027 International Conference & Exhibition 30 January 2027 – 3 February 2027
- Introduction to Pre-Clinical Drug Discovery Speaker · 30 January 2027
Spoke alongside
People who have shared a session with Sinead at events on B2DB.
- Juliet Morgan Principal Scientist · Sygnature Discovery 1 shared session
- Lynette Ongeri DMPK Principal Scientist · Sygnature Discovery 1 shared session